These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 32264239

  • 1. Biocompatible and stable magnetosome minerals coated with poly-l-lysine, citric acid, oleic acid, and carboxy-methyl-dextran for application in the magnetic hyperthermia treatment of tumors.
    Mandawala C, Chebbi I, Durand-Dubief M, Le Fèvre R, Hamdous Y, Guyot F, Alphandéry E.
    J Mater Chem B; 2017 Sep 28; 5(36):7644-7660. PubMed ID: 32264239
    [Abstract] [Full Text] [Related]

  • 2. Biocompatible coated magnetosome minerals with various organization and cellular interaction properties induce cytotoxicity towards RG-2 and GL-261 glioma cells in the presence of an alternating magnetic field.
    Hamdous Y, Chebbi I, Mandawala C, Le Fèvre R, Guyot F, Seksek O, Alphandéry E.
    J Nanobiotechnology; 2017 Oct 17; 15(1):74. PubMed ID: 29041937
    [Abstract] [Full Text] [Related]

  • 3. Development of non-pyrogenic magnetosome minerals coated with poly-l-lysine leading to full disappearance of intracranial U87-Luc glioblastoma in 100% of treated mice using magnetic hyperthermia.
    Alphandéry E, Idbaih A, Adam C, Delattre JY, Schmitt C, Guyot F, Chebbi I.
    Biomaterials; 2017 Oct 17; 141():210-222. PubMed ID: 28689117
    [Abstract] [Full Text] [Related]

  • 4. Enhanced antitumor efficacy of biocompatible magnetosomes for the magnetic hyperthermia treatment of glioblastoma.
    Le Fèvre R, Durand-Dubief M, Chebbi I, Mandawala C, Lagroix F, Valet JP, Idbaih A, Adam C, Delattre JY, Schmitt C, Maake C, Guyot F, Alphandéry E.
    Theranostics; 2017 Oct 17; 7(18):4618-4631. PubMed ID: 29158849
    [Abstract] [Full Text] [Related]

  • 5. Non-pyrogenic highly pure magnetosomes for efficient hyperthermia treatment of prostate cancer.
    Nguyen TN, Chebbi I, Le Fèvre R, Guyot F, Alphandéry E.
    Appl Microbiol Biotechnol; 2023 Feb 17; 107(4):1159-1176. PubMed ID: 36633624
    [Abstract] [Full Text] [Related]

  • 6. Biodegraded magnetosomes with reduced size and heating power maintain a persistent activity against intracranial U87-Luc mouse GBM tumors.
    Alphandéry E, Idbaih A, Adam C, Delattre JY, Schmitt C, Gazeau F, Guyot F, Chebbi I.
    J Nanobiotechnology; 2019 Dec 23; 17(1):126. PubMed ID: 31870376
    [Abstract] [Full Text] [Related]

  • 7. Bio-synthesized iron oxide nanoparticles for cancer treatment.
    Alphandéry E.
    Int J Pharm; 2020 Aug 30; 586():119472. PubMed ID: 32590095
    [Abstract] [Full Text] [Related]

  • 8. Stable pharmaceutical composition of cryo-protected non-pyrogenic isotonic chains of magnetosomes for efficient tumor cell destruction at 45 ± 1 °C under alternating magnetic field or ultrasound application.
    Nguyen TN, Chebbi I, Le Fèvre R, Guyot F, Alphandéry E.
    Nanoscale; 2024 Oct 17; 16(40):18984-18997. PubMed ID: 39297787
    [Abstract] [Full Text] [Related]

  • 9. A Comparative Study of Receptor-Targeted Magnetosome and HSA-Coated Iron Oxide Nanoparticles as MRI Contrast-Enhancing Agent in Animal Cancer Model.
    Erdal E, Demirbilek M, Yeh Y, Akbal Ö, Ruff L, Bozkurt D, Cabuk A, Senel Y, Gumuskaya B, Algın O, Colak S, Esener S, Denkbas EB.
    Appl Biochem Biotechnol; 2018 May 17; 185(1):91-113. PubMed ID: 29082480
    [Abstract] [Full Text] [Related]

  • 10. Chains of magnetosomes extracted from AMB-1 magnetotactic bacteria for application in alternative magnetic field cancer therapy.
    Alphandéry E, Faure S, Seksek O, Guyot F, Chebbi I.
    ACS Nano; 2011 Aug 23; 5(8):6279-96. PubMed ID: 21732678
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic evaluation of magnetic hyperthermia using Fe3O4-aminosilane-coated iron oxide nanoparticles in glioblastoma animal model.
    Rego GNA, Mamani JB, Souza TKF, Nucci MP, Silva HRD, Gamarra LF.
    Einstein (Sao Paulo); 2019 Aug 01; 17(4):eAO4786. PubMed ID: 31390427
    [Abstract] [Full Text] [Related]

  • 12. Chains of magnetosomes with controlled endotoxin release and partial tumor occupation induce full destruction of intracranial U87-Luc glioma in mice under the application of an alternating magnetic field.
    Alphandéry E, Idbaih A, Adam C, Delattre JY, Schmitt C, Guyot F, Chebbi I.
    J Control Release; 2017 Sep 28; 262():259-272. PubMed ID: 28713041
    [Abstract] [Full Text] [Related]

  • 13. Assessment of intratumor non-antibody directed iron oxide nanoparticle hyperthermia cancer therapy and antibody directed IONP uptake in murine and human cells.
    Hoopes P, Tate J, Ogden J, Strawbridge R, Fiering S, Petryk A, Cassim S, Giustini A, Demidenko E, Ivkov R, Barry S, Chinn P, Foreman A.
    Proc SPIE Int Soc Opt Eng; 2009 Feb 23; 7181():71810P. PubMed ID: 25346583
    [Abstract] [Full Text] [Related]

  • 14. Preparation of chains of magnetosomes, isolated from Magnetospirillum magneticum strain AMB-1 magnetotactic bacteria, yielding efficient treatment of tumors using magnetic hyperthermia.
    Alphandéry E, Guyot F, Chebbi I.
    Int J Pharm; 2012 Sep 15; 434(1-2):444-52. PubMed ID: 22698862
    [Abstract] [Full Text] [Related]

  • 15. Applications of magnetotactic bacteria and magnetosome for cancer treatment: A review emphasizing on practical and mechanistic aspects.
    Alphandéry E.
    Drug Discov Today; 2020 Aug 15; 25(8):1444-1452. PubMed ID: 32561298
    [Abstract] [Full Text] [Related]

  • 16. The effect of iron-chelating agents on Magnetospirillum magneticum strain AMB-1: stimulated growth and magnetosome production and improved magnetosome heating properties.
    Alphandéry E, Amor M, Guyot F, Chebbi I.
    Appl Microbiol Biotechnol; 2012 Nov 15; 96(3):663-70. PubMed ID: 22707052
    [Abstract] [Full Text] [Related]

  • 17. Stabilizing Alginate Confinement and Polymer Coating of CO-Releasing Molecules Supported on Iron Oxide Nanoparticles To Trigger the CO Release by Magnetic Heating.
    Meyer H, Winkler F, Kunz P, Schmidt AM, Hamacher A, Kassack MU, Janiak C.
    Inorg Chem; 2015 Dec 07; 54(23):11236-46. PubMed ID: 26595858
    [Abstract] [Full Text] [Related]

  • 18. 99mTc-, 90Y-, and 177Lu-Labeled Iron Oxide Nanoflowers Designed for Potential Use in Dual Magnetic Hyperthermia/Radionuclide Cancer Therapy and Diagnosis.
    Ognjanović M, Radović M, Mirković M, Prijović Ž, Puerto Morales MD, Čeh M, Vranješ-Đurić S, Antić B.
    ACS Appl Mater Interfaces; 2019 Nov 06; 11(44):41109-41117. PubMed ID: 31610125
    [Abstract] [Full Text] [Related]

  • 19. Iron oxide nanoparticle hyperthermia and chemotherapy cancer treatment.
    Petryk A, Giustini A, Ryan P, Strawbridge R, Hoopes P.
    Proc SPIE Int Soc Opt Eng; 2009 Feb 23; 7181():71810N. PubMed ID: 25346581
    [Abstract] [Full Text] [Related]

  • 20. Effects of Environmental Conditions on High-Yield Magnetosome Production by Magnetospirillum gryphiswaldense MSR-1.
    Hatami-Giklou Jajan L, Hosseini SN, Ghorbani M, Mousavi SF, Ghareyazie B, Abolhassani M.
    Iran Biomed J; 2019 May 23; 23(3):209-19. PubMed ID: 30797225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.